ADSL and mastitis: Based on all the evidence presented, results demonstrate that two plectasin-derived AMPs (NZ2114 and MP1102) had high efficacy in vitro (milk and bovine mammary epithelial cell) and in vivo (mouse model of mastitis) against S. aureus.